Literature DB >> 24846140

Chaperonin-containing TCP-1 complex directly binds to the cytoplasmic domain of the LOX-1 receptor.

Deenadayalan Bakthavatsalam1, Roh Hun Soung2, David J Tweardy3, Wah Chiu2, Richard A F Dixon4, Darren G Woodside4.   

Abstract

Lectin-like oxidized low-density lipoprotein receptor (LOX-1) is a scavenger receptor that binds oxidized low-density lipoprotein (OxLDL) and has a role in atherosclerosis development. The N-terminus intracellular region (cytoplasmic domain) of LOX-1 mediates receptor internalization and trafficking, potentially through intracellular protein interactions. Using affinity isolation, we identified 6 of the 8 components of the chaperonin-containing TCP-1 (CCT) complex bound to LOX-1 cytoplasmic domain, which we verified by coimmunoprecipitation and immunostaining in human umbilical vein endothelial cells. We found that the interaction between CCT and LOX-1 is direct and ATP-dependent and that OxLDL suppressed this interaction. Understanding the association between LOX-1 and the CCT complex may facilitate the design of novel therapies for cardiovascular disease.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; CCT complex; Lectin-like oxidized low-density lipoprotein receptor; Protein–protein interaction

Mesh:

Substances:

Year:  2014        PMID: 24846140      PMCID: PMC4100626          DOI: 10.1016/j.febslet.2014.04.049

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  44 in total

1.  Purification of the cytosolic chaperonin TRiC from bovine testis.

Authors:  R G Ferreyra; J Frydman
Journal:  Methods Mol Biol       Date:  2000

2.  BBS6, BBS10, and BBS12 form a complex with CCT/TRiC family chaperonins and mediate BBSome assembly.

Authors:  Seongjin Seo; Lisa M Baye; Nathan P Schulz; John S Beck; Qihong Zhang; Diane C Slusarski; Val C Sheffield
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

3.  LOX-1 supports adhesion of Gram-positive and Gram-negative bacteria.

Authors:  T Shimaoka; N Kume; M Minami; K Hayashida; T Sawamura; T Kita; S Yonehara
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

4.  ROCK2 associates with lectin-like oxidized LDL receptor-1 and mediates oxidized LDL-induced IL-8 production.

Authors:  Mark D Mattaliano; Joe Wooters; Heather H Shih; Janet E Paulsen
Journal:  Am J Physiol Cell Physiol       Date:  2010-02-24       Impact factor: 4.249

5.  Human TRiC complex purified from HeLa cells contains all eight CCT subunits and is active in vitro.

Authors:  Kelly M Knee; Oksana A Sergeeva; Jonathan A King
Journal:  Cell Stress Chaperones       Date:  2012-08-13       Impact factor: 3.667

Review 6.  LOX-1/LOXIN: the yin/yang of atheroscleorosis.

Authors:  Ruggiero Mango; Irene Marta Predazzi; Francesco Romeo; Giuseppe Novelli
Journal:  Cardiovasc Drugs Ther       Date:  2011-10       Impact factor: 3.727

7.  Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation.

Authors:  Yves Delneste; Giovanni Magistrelli; Jean Gauchat; Jean Haeuw; Jean Aubry; Kayo Nakamura; Naoko Kawakami-Honda; Liliane Goetsch; Tatsuya Sawamura; Jean Bonnefoy; Pascale Jeannin
Journal:  Immunity       Date:  2002-09       Impact factor: 31.745

8.  Interaction of p53 with the CCT complex promotes protein folding and wild-type p53 activity.

Authors:  Antonio Garcia Trinidad; Patricia A J Muller; Jorge Cuellar; Marta Klejnot; Max Nobis; José María Valpuesta; Karen H Vousden
Journal:  Mol Cell       Date:  2013-06-06       Impact factor: 17.970

9.  Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular disease.

Authors:  Sam L Stephen; Katie Freestone; Sarah Dunn; Michael W Twigg; Shervanthi Homer-Vanniasinkam; John H Walker; Stephen B Wheatcroft; Sreenivasan Ponnambalam
Journal:  Int J Hypertens       Date:  2010-08-17       Impact factor: 2.420

10.  Symmetry-free cryo-EM structures of the chaperonin TRiC along its ATPase-driven conformational cycle.

Authors:  Yao Cong; Gunnar F Schröder; Anne S Meyer; Joanita Jakana; Boxue Ma; Matthew T Dougherty; Michael F Schmid; Stefanie Reissmann; Michael Levitt; Steven L Ludtke; Judith Frydman; Wah Chiu
Journal:  EMBO J       Date:  2011-11-01       Impact factor: 11.598

View more
  6 in total

1.  Regulation of GPCR expression through an interaction with CCT7, a subunit of the CCT/TRiC complex.

Authors:  Samuel Génier; Jade Degrandmaison; Pierrick Moreau; Pascale Labrecque; Terence E Hébert; Jean-Luc Parent
Journal:  Mol Biol Cell       Date:  2016-10-05       Impact factor: 4.138

2.  Integrated genetic and epigenetic prediction of coronary heart disease in the Framingham Heart Study.

Authors:  Meeshanthini V Dogan; Isabella M Grumbach; Jacob J Michaelson; Robert A Philibert
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

3.  The CCT chaperonin is a novel regulator of Ca2+ signaling through modulation of Orai1 trafficking.

Authors:  Rawad Hodeify; Manjula Nandakumar; Maryam Own; Raphael J Courjaret; Johannes Graumann; Satanay Z Hubrack; Khaled Machaca
Journal:  Sci Adv       Date:  2018-09-26       Impact factor: 14.136

4.  Overexpressing CCT6A Contributes To Cancer Cell Growth By Affecting The G1-To-S Phase Transition And Predicts A Negative Prognosis In Hepatocellular Carcinoma.

Authors:  Guofen Zeng; Jialiang Wang; Yanlin Huang; Yifan Lian; Dongmei Chen; Huan Wei; Chaoshuang Lin; Yuehua Huang
Journal:  Onco Targets Ther       Date:  2019-11-29       Impact factor: 4.147

5.  Identification of Inhibitors of Integrin Cytoplasmic Domain Interactions With Syk.

Authors:  Deenadayalan Bakthavatsalam; John W Craft; Anna Kazansky; Nghi Nguyen; Goeun Bae; Amy R Caivano; C William Gundlach; Asra Aslam; Safa Ali; Shashikant Gupta; Sophie Y Lin; Hema D Parthiban; Peter Vanderslice; Clifford C Stephan; Darren G Woodside
Journal:  Front Immunol       Date:  2021-01-08       Impact factor: 7.561

Review 6.  Contribution of the Type II Chaperonin, TRiC/CCT, to Oncogenesis.

Authors:  Soung-Hun Roh; Moses Kasembeli; Deenadayalan Bakthavatsalam; Wah Chiu; David J Tweardy
Journal:  Int J Mol Sci       Date:  2015-11-06       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.